Our events

IGBA at the 80^th Session of the United Nations General Assembly and High-Level Meeting on NCDs:

By the end of September, world leaders will meet in New York for the United Nations 80^th General Assembly, and the global health community will gather around the High-Level Meeting on Non-Communicable Diseases, happening on 25 September.

For the first time, IGBA will be bringing the voice of generic and biosimilar manufacturers from all over the globe to this important event. As we remain committed to our goal of promoting the widest possible access to quality-assured, safe, efficacious, cost-effective medicines to patients globally, we will contribute our views to several events.

Bridging the gap: Scaling innovative approaches to NCD medicine access in LMICs.

Tuesday, 23 September

By registration.

Hosted by Access to Medicines Foundation, Medicines Patent Pool, NCD Alliance

A roundtable discussion focusing on discussing best practices to improve access to medicines and NCD medicines in LMICs, key implementers, common objectives among stakeholders, and scalable and transferable models across geographies and healthcare systems, among others.

Reimagining Diabetes Care: Innovative Pathways to Equity, Access, and Impact

Tuesday, 23 September

By registration

Hosted by Accenture and PATH

A roundtable convening a select group of leaders from government, multilateral organizations, civil society, and the private sector to examine critical gaps and opportunities in diabetes care delivery, and to explore case studies and game-changing approaches, including care bundles, coordinated and digital care, and innovative financing.

Advancing access and financing for NCD medicines and products

Wednesday, 24 September

By registration.

Hosted by Coalition for Access to NCD medicines and products, Novo Nordisk and IGBA

A high-level event on the sidelines of UNGA to bring together governments, civil society, global health partners and technical experts to spotlight leadership and drive forward collective action. The event will offer a space to consolidate country commitments, and define the next steps needed to close the financing and access gap for NCD medicines and products.